Catherine Ji

Catherine Ji

Auto-generated profile, based on publicly available information

Catherine Ji

Research and Innovation, North York General Hospital, 4001 Leslie St., Room LE-140, Toronto, ON M2K 1E1, Canada; Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, 500 University Avenue, 5th Floor, Toronto, Ontario M5G 1V7, Canada; Toronto Western Family Health Team, University Health Network, 440 Bathurst Street, 3(rd) Floor, Toronto, ON M5T 2S6, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2022 in Vaccine
Verified
Journal Article
Open access
CJCatherine Ji
Catherine Ji
PPPierre-Philippe Piché-Renaud
Pierre-Philippe Piché-Renaud
JAJemisha Apajee
Jemisha Apajee
ESEllen Stephenson
Ellen Stephenson
MFMilena Forte
Milena Forte
KTKaren Tu
Karen Tu
The COVID-19 pandemic has caused a disruption in childhood immunization coverage around the world. This study aimed to determine the change in immunization coverage for children under 2 years old in Ontario, Canada, comparing time periods pre-pandemic to during the first year of the pandemic. Observational retrospective open cohort study, using primary care electronic medical record data from the University of Toronto Practice-Based Research Network (UTOPIAN) database, from January 2019 to December 2020. Children under 2 years old who had at least 2 visits recorded in UTOPIAN were included. We measured up-to-date (UTD) immunization coverage rates, overall and by type of vaccine (DTaP-IPV-Hib, PCV13, Rota, Men-C-C, MMR, Var), and on-time immunization coverage rates by age milestone (2, 4, 6, 12, 15, 18 months). We compared average coverage rates over 3 periods of time: January 2019-March 2020 (T1); March-July 2020 (T2); and August-December 2020 (T3). 12,313 children were included. Overall UTD coverage for all children was 71.0% in T1, dropped by 5.7% (95% CI: −6.2, −5.1) in T2, slightly increased in T3 but remained lower than in T1. MMR vaccine UTD coverage slightly decreased in T2 and T3 by approximately 2%. The largest decreases were seen at ages 15-month and 18-month old, with drops in on-time coverage of 14.7% (95% CI: −18.7, −10.6) and 16.4% (95% CI: −20.0, −12.8) respectively during T2. When stratified by sociodemographic characteristics, no specific subgroup of children was found to have been differentially impacted by the pandemic. Childhood immunization coverage rates for children under 2 years in Ontario decreased significantly during the early period of the COVID-19 pandemic and only partially recovered during the rest of 2020. Public health and educational interventions for providers and parents are needed to ensure adequate catch-up of delayed/missed immunizations to prevent potential outbreaks of vaccine-preventable diseases.

15 June 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
PPPierre-Philippe Piché-Renaud
Pierre-Philippe Piché-Renaud
ELErika Yue Lee
Erika Yue Lee
CJCatherine Ji
Catherine Ji
JHJenny Yu Qing Huang
Jenny Yu Qing Huang
EUElizabeth Uleryk
Elizabeth Uleryk
UAUpton D. Allen
Upton D. Allen
Synthesize the available evidence on the immunogenicity, safety, and effectiveness of live-attenuated varicella vaccine in solid organ transplant (SOT) recipients. Medline and EMBASE were searched using predefined search terms to identify relevant studies. Included articles reported varicella vaccine administration in the post-transplant period in children and adults. Pooled proportion of transplant recipients who seroconverted and who developed vaccine-strain varicella and varicella disease were generated. Eighteen articles (14 observational studies, 4 case reports) were included, reporting on 711 transplant recipients who received the varicella vaccine. The pooled proportion was 88.2% (95% confidence interval [CI] 78.0%-96.0%, 13 studies) for vaccinees who seroconverted, 0% (0%-1.2%, 13 studies) for vaccine-strain varicella and 0.8% (0%-4.9%, 9 studies) for varicella disease. Most studies followed clinical guidelines for administering live-attenuated vaccines with criteria that could include being at least one-year post-transplant, two months post-rejection episode, and on low-dose immunosuppressive medications. Varicella vaccination in transplant recipients was overall safe in included studies, with few cases of vaccine-strain induced varicella or vaccine failure, and while it was immunogenic, the proportion of recipients who seroconverted was lower than that seen in the general population. Our data support varicella vaccination in select pediatric solid organ transplant recipients.

30 January 2025 in Vaccine
Verified
Journal Article
Open access
CJCatherine Ji
Catherine Ji
ASArrani Senthinathan
Arrani Senthinathan
JAJemisha Apajee
Jemisha Apajee
VDVinita Dubey
Vinita Dubey
MFMilena Forte
Milena Forte
KTKaren Tu
Karen Tu
To assess immunization coverage for routine vaccinations in children (aged 4-7 years) and teenagers (aged 14-17 years) during the COVID-19 pandemic compared to the pre-pandemic period, in Ontario, Canada. Retrospective cohort study using primary care electronic medical records data from the University of Toronto Practice-Based Research Network database from January 2018 to June 2022. Monthly estimates of vaccine up-to-date (UTD) coverage (defined as 1 dose of tetanus, diphtheria, and acellular pertussis (Tdap)-containing and 1 dose of measles, mumps and rubella-containing vaccines received after the 4th birthday for children; and 1 dose of Tdap-containing vaccine received after the 14th birthday for teenagers) and time series regression analysis were used to compare changes in mean coverage before and during the pandemic. We also examined if changes in coverage estimates over time were associated with sociodemographic factors. 30,010 children and 31,624 teenagers were included. Mean monthly UTD coverage for children decreased significantly from 48.7 % (SD 2.1) pre-pandemic (January 2018 - February 2020) to 44.3 % (SD 1.3) in mid-pandemic period (July 2020-June 2021), and remained significantly lower in later pandemic period (July 2021 - June 2022). Mean monthly UTD coverage for teenagers was 34.6 % (SD 0.9) pre-pandemic and decreased to 16.7 % (SD 0.6) in later pandemic period. When adjusted for baseline differences, teenagers from neighborhoods with higher income, lower proportions of racialized and newcomer populations and from rural areas experienced larger decreases in UTD coverage during the pandemic. No significant differences were found in UTD coverage among children across the various sociodemographic factors. Significant declines in immunization coverage for children and teenagers in Ontario were still observed by June 2022, highlighting the need to further study the long-term impact of the pandemic and implement effective catch-up interventions to increase immunization coverage and prevent outbreaks of vaccine-preventable diseases.

1 January 2024 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
YMYuki Meng
Yuki Meng
CCChristopher Chiu
Christopher Chiu
MKMamta Kapoor
Mamta Kapoor
SLShelly-Anne Li
Shelly-Anne Li
NKNavaldeep Kaur
Navaldeep Kaur
CPChristine Papoushek
Christine Papoushek
Background: Depression affects approximately 280 million individuals globally and it is a leading cause of disability. Despite effective medication options, 50% of patients prematurely discontinue antidepressants within 6 months. We sought to understand patients’ perspectives regarding their needs and expectations related to antidepressants. Objectives: To identify and describe enablers and barriers that influence adult patients’ medication adherence in depression treatment and to explore patients’ educational needs on initiating or continuing antidepressant therapy. Methods: Qualitative descriptive study was conducted using individual, semi-structured interviews of adult patients with depression who were prescribed an antidepressant within 3 months of study recruitment at an urban primary care clinic in Toronto, Canada. Thirteen participants were interviewed. Interviews were recorded and transcribed verbatim for inductive thematic analysis. Results: Six themes emerged: safety and effectiveness of antidepressant, understanding of depression and its management, medication administration, healthcare experiences in the treatment of depression, and social influences and relationships. Barriers to adherence included adverse effects of antidepressants, preference for non-pharmacological therapies, uncertainty about therapeutic effects, and social stigma. In contrast, enablers were positive responses from antidepressants, fear of relapse, reminder aids, established routine, and a trusting patient-provider relationship. Participants desired access to reliable, evidence-based, and personalized educational information delivered through verbal, written, and digital formats to support antidepressant adherence. Conclusion: To overcome the identified barriers, educational strategies should involve both patients and their prescribers to identify patient-specific needs and treatment goals, engage in shared decision-making, and maintain consistent follow-up to support antidepressant adherence.

1 January 2023 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
MMMilena Music
Milena Music
NTNicholas Taylor
Nicholas Taylor
CMChristopher McChesney
Christopher McChesney
CKChristian Krustev
Christian Krustev
ACAlexandra Chirila
Alexandra Chirila
CJCatherine Ji
Catherine Ji
Introduction/Objectives: Addressing vaccine hesitancy has become an increasingly important public health priority in recent years. There is a paucity of studies that have focused on vaccine hesitancy among older adults, who are known to be at greater risk of complications from infections such as COVID-19. We aim to explore the attitudes and beliefs of older adults regarding COVID-19 and influenza vaccines in Toronto, Ontario. Methods: Older adults enrolled in the Student Senior Isolation Prevention Partnership (SSIPP) program at the University of Toronto were contacted to participate in a phone survey and semi-structured interview. Survey data was analyzed descriptively, and attitude toward vaccination was compared between sociodemographic groups by using Fisher’s exact test. Interview audio files were transcribed verbatim and analyzed inductively for themes and sub-themes. Results: All thirty-three (100%) older adults reported that they had received the first and second doses of the COVID-19 vaccine. Twenty-six (78.8%) participants reported intent to get vaccinated against influenza or had already received the influenza vaccine that year. Notably, only 2 out 7 (28.6%) individuals who did not plan to get vaccinated against influenza believed that vaccines offered by health providers are beneficial and only 3 out of 7 (42.9%) agreed that getting vaccines is a good way to protect oneself from disease. No other significant differences in attitudes among participants were found when compared by gender, ethnicity, or education level. The qualitative data analysis of interview transcripts identified 5 themes that impact vaccine decision making: safety, trust, mistrust, healthcare experience, and information dissemination and education. Conclusions: Our data showed that older adults in the SSIPP program generally had positive views toward vaccination, especially toward the COVID-19 vaccines. However, several concerns regarding the effectiveness of the vaccines were brought up in interviews, such as the speed at which the vaccines were produced and the inconsistency in government messaging.

20 January 2026 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
ABAdam Bleik
Adam Bleik
PMPatricia Marr
Patricia Marr
SLShelly-Anne Li
Shelly-Anne Li
DKDebbie Kwan
Debbie Kwan
CJCatherine Ji
Catherine Ji
CPChristine Papoushek
Christine Papoushek
Background: Depression and anxiety affect nearly 1 in 4 Canadians. Traditional patient education materials, such as handouts, are often lengthy and difficult to understand, leading to disengagement. Human-like artificial intelligence (AI) avatars offer a novel way to supplement education by delivering consistent, engaging video content that mimics human interaction and is easily accessible online. Objective: This pilot study aimed to develop a human-like, non-generative AI avatar educational video to support education on antidepressants for patients living with depression and anxiety. The secondary objectives were to evaluate participants perceptions of the tool across 3 domains: credibility, satisfaction, and understanding. Methods: The video was developed through 2 Plan-Do-Study-Act (PDSA) cycles, informed by prior research on patient-reported barriers and enablers to antidepressant use. After viewing the video, participants completed a survey assessing the 3 domains. Success was predefined as ≥60% of participants rating each domain ≥4 on a 5-point Likert scale. Open-ended feedback was summarized descriptively to help inform revisions. Results: Fifteen University Health Network (UHN) Patient Partners participated in PDSA Cycle 1, most with lived experience of depression or anxiety and high digital literacy. Success thresholds were achieved for credibility (75%) and satisfaction (67%) but not for understanding (50%). After revisions, 10 participants from the original group completed PDSA Cycle 2, where all domains exceeded thresholds (credibility 90%, satisfaction 85%, understanding 82%). Participants described the tool as trustworthy, clear, and engaging. Conclusion: This pilot study demonstrated that human-like, non-generative AI avatars can be an effective supplementary educational tool to deliver education on antidepressants for individuals with depression and anxiety. The tool demonstrated acceptability across credibility, satisfaction, and perceived understanding, highlighting its potential to enhance patient engagement and access to reliable information. As a scalable and adaptable format, avatar-based education may extend beyond mental health to other conditions, languages, and clinical settings. Future studies should examine its impact on knowledge retention, treatment adherence, and integration into clinical practice.